The WiSE-UP Study is a prospective, real-world, observational study aimed at understanding acute and long-term product performance, including patient safety, clinical outcomes, and CRT response information associated with the use of the market-released WiSE System.
Age
22–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient or legally authorized representative can provide written authorization and/or consent per institution requirements.
Patient is intended to receive a WiSE System and passed the acoustic window screening
Patient who is, or will be, accessible for follow-up.
Participation is not excluded by local law.
Patient is not enrolled in a concurrent drug and/or device study that may confound the Registry results.
